No coding mutations are detected in the peroxisome proliferator- activated receptor-γ gene in Japanese patients with lipoatrophic diabetes

Diabetes

Volumn 46, Issue 11, 1997, Pages 1904-1906

  Okazawa, Hideki ^a   Mori, Hiroyuki ^a   Tamori, Yoshikazu ^a   Araki, Satoshi ^a   Niki, Toshiharu ^a   Masugi, Jiro ^a   Kawanishi, Masatoshi ^a   Kubota, Takanori ^a   Shinoda, Hiroaki ^a   Kasuga, Masato ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CELL NUCLEUS RECEPTOR; COMPLEMENTARY DNA; PEROXISOME PROLIFERATOR;

ADIPOCYTE; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPOATROPHIC DIABETES MELLITUS; MALE; MOLECULAR CLONING; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECEPTOR GENE; RELATIVE; SIBLING;

EID: 15144347552     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.11.1904     Document Type: Article

References (11)

1. Lawrence RD: Lipodystrophy and hepatomegaly with diabetes, lipemia, and other metabolic disturbances. Lancet i:724-731, 1946
2. Magré J, Reynet C, Capeau J, Blivet MJ, Picard J: In vitro studies of insulin resistance in patients with lipoatrophic diabetes. Diabetes 37:421-428, 1988
3. Desbois-Mouthon C, Magré J, Amselen S, Reynet C, Blivet MJ, Goossens M, Capeau J, Besmond C: Lipoatrophic diabetes: genetic exclusion of the insulin receptor gene. J Clin Endocrinol Metab 80:314-319, 1995
4. Van der Vorm ER, Kuipers A, Bonenkamp JW, Heuer WJ, Van Maldergem L, Herwig J, Maassen JA: Patients with lipodystrophic diabetes mellitus of the Seip-Berardinelli type express normal insulin receptors. Diabetologia 36:172-174, 1993
5. Gedde-Dahl Jr T, Trygstad O, Van Maldergem L, Magré J, Van der Hagen CB, Olaisen B, Stenersen M, Mevåg B, and The Berardinelli-Seip Study Group: Genetics of the Berardinelli-Seip syndrome (congenital generalized lipodystrophy) in Norway: epidemiology and gene mapping. Acta Paediatr Scand 413 (Suppl.) :52-58, 1996
6. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibloblasts by PPAR-γ2, a lipid-activated transcription factor. Cell 79:1147-1156, 1994
7. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkinson WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR-γ). J Biol Chem 270:12953-12956, 1995
8. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM: mPPAR-γ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224-1234, 1994
9. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK: Structural organization of mouse peroxisome proliferator-activated receptor g(mPPAR-γ) gene: alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci USA 92:7921-7926, 1995
10. Eibrecht A, Chen Y, Cullinan CA, Hayes N, Leibowitz MD, Moller DE, Berger J: Molecular cloning, expression and characterization of human peroxisome proliferator-activated receptors γ1 and γ2. Biochem Biophys Res Commun 224:431-437, 1996
11. Wu Z, Xie Y, Bucher NLR, Farmer SR: Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes Dev 9:2350-2363, 1905